VAPRISOL SUMMARY
Vaprisol® (conivaptan hydrochloride injection)
VAPRISOL® (conivaptan hydrochloride injection) is a nonpeptide, dual antagonist of arginine vasopressin (AVP) V1A and V2 receptors.
VAPRISOL is indicated for the treatment of euvolemic hyponatremia (e.g., the syndrome of inappropriate secretion of antidiuretic hormone, or in the setting of hypothyroidism, adrenal insufficiency, pulmonary disorders, etc.) in hospitalized patients.
VAPRISOL is not indicated for the treatment of patients with congestive heart failure. (See PRECAUTIONS)
|